Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease. The FIB-4 score can be used to identify at-risk patients with NAFLD and, if necessary, refer them for further hepatologic evaluation. It is a simple and cost-effective screening method that is suitable for the primary care setting.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Compression
Lymphoedema and chronic wounds
- Epilepsy
The treatment of refractory status epilepticus – an overview
- Podiatry support to improve quality of life
Patient mobility with a foot wound
- Rare diseases
Cogan syndrome – a clinical challenge
- Polymyalgia rheumatica and giant cell arteritis
New consensus paper recommends “treat-to-target” strategy
- Threat from Aedes mosquitoes
Dengue, Zika and Chikungunya viruses on the rise
- Systemic lupus erythematosus
DORIS and LLDAS are also worthwhile for severe cases
- Malnutrition in old age